Wealth Enhancement Advisory Services’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
Other funds holding BBP
Wealth Enhancement Advisory Services's BBP Position: Q3 2026 in Review
Wealth Enhancement Advisory Services increased its Virtus Biotech ETF (BBP) stake by 12% in Q3 2026, buying an estimated $1.24M and bringing the position to 116,551 shares worth $11.8M. The position accounts for 0.02% of the portfolio, ranked #660.
Wealth Enhancement Advisory Services first reported a position in BBP in Q2 2025 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold BBP as of Q3 2026.
- Wealth Enhancement Advisory Services held 116,551 shares of Virtus Biotech ETF worth $11.8M as of Q3 2026.
- Wealth Enhancement Advisory Services bought 12,177 Virtus Biotech ETF shares in Q3 2026, an estimated $1.24M.
- Virtus Biotech ETF made up 0.02% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #660 holding.
- Wealth Enhancement Advisory Services first reported a position in Virtus Biotech ETF in Q2 2025 and has held it in 4 quarters since.
- 33 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.